Literature DB >> 2888059

Non-competitive regulation of phencyclidine/sigma-receptors by the N-methyl-D-aspartate receptor antagonist D-(-)-2-amino-5-phosphonovaleric acid.

D C Javitt, A Jotkowitz, R Sircar, S R Zukin.   

Abstract

D-(-)-2-Amino-5-phosphonovaleric acid (D(-)AP5), a selective, potent competitive antagonist of N-methyl-D-aspartate (NMDA)-type excitatory amino acid receptors was used to investigate the relationship between NMDA receptors and phencyclidine (PCP) binding. Incubation of rat brain membranes with D(-)AP5 decreased the apparent number of PCP/sigma-receptors in dose-dependent fashion without affecting their affinity for [2-thienyl-3H]cyclohexylpiperidine (TCP). These data, taken together with electrophysiological evidence that PCP non-competitively antagonizes NMDA receptor-mediated transmission, are consistent with the hypothesis that the PCP/sigma-receptor may be situated in or near a channel regulated by an NMDA receptor complex.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2888059     DOI: 10.1016/0304-3940(87)90632-x

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

Review 1.  From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment.

Authors:  Bita Moghaddam; Daniel Javitt
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

2.  Orbitofrontal cortex neurons as a common target for classic and glutamatergic antipsychotic drugs.

Authors:  Houman Homayoun; Bita Moghaddam
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-12       Impact factor: 11.205

3.  A comparison between the in vivo and in vitro activity of five potent and competitive NMDA antagonists.

Authors:  D Lodge; S N Davies; M G Jones; J Millar; D T Manallack; P L Ornstein; A J Verberne; N Young; P M Beart
Journal:  Br J Pharmacol       Date:  1988-11       Impact factor: 8.739

Review 4.  Excitation-inhibition discoordination in rodent models of mental disorders.

Authors:  André A Fenton
Journal:  Biol Psychiatry       Date:  2015-03-18       Impact factor: 13.382

Review 5.  How Nox2-containing NADPH oxidase affects cortical circuits in the NMDA receptor antagonist model of schizophrenia.

Authors:  Xin Wang; António Pinto-Duarte; Terrence J Sejnowski; M Margarita Behrens
Journal:  Antioxid Redox Signal       Date:  2012-10-18       Impact factor: 8.401

6.  Interaction of [3H]MK-801 with multiple states of the N-methyl-D-aspartate receptor complex of rat brain.

Authors:  D C Javitt; S R Zukin
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

Review 7.  Nicotine and nicotinic system in hypoglutamatergic models of schizophrenia.

Authors:  Yousef Tizabi
Journal:  Neurotox Res       Date:  2007-12       Impact factor: 3.911

8.  Coexpression of N-methyl-D-aspartate and phencyclidine receptors in Xenopus oocytes injected with rat brain mRNA.

Authors:  L Kushner; J Lerma; R S Zukin; M V Bennett
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

9.  Neurofilament light interaction with GluN1 modulates neurotransmission and schizophrenia-associated behaviors.

Authors:  Aidong Yuan; Henry Sershen; Balapal S Basavarajappa; John F Smiley; Audrey Hashim; Cynthia Bleiwas; Martin Berg; David N Guifoyle; Shivakumar Subbanna; Sandipkumar Darji; Asok Kumar; Mala V Rao; Donald A Wilson; Jean-Pierre Julien; Daniel C Javitt; Ralph A Nixon
Journal:  Transl Psychiatry       Date:  2018-08-24       Impact factor: 6.222

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.